Pharmaron Beijing Company Description

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others.

The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development.

It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services.

In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies.

Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.

Pharmaron Beijing Co., Ltd.

Country	China
Founded	2004
Industry	Commercial Physical and Biological Research
Employees	21,370
CEO	Boliang Lou

Contact Details

Address: Building 1 Beijing, 100176 China
Website	pharmaron.com

Stock Details

Ticker Symbol	17Q1
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	8731

Key Executives

Name	Position
Boliang Lou	Chief Executive Officer
Shing Chung Li	Chief Financial Officer
Xiaoqiang Lou	Chief Operating Officer